CDMO

The Centres were inaugurated at the Institute’s Technology Research Park

HRV Global Life Sciences (HRV Pharma), India’s first integrated Virtual API and Pharmtech company, announced a unique,…

While India’s CDMOs are well positioned to capitalise on the booming GLP-1 market, the recurring episodes of contaminated cough…

The ₹192.5 crore transaction marks Granules India's entry into the CDMO segment and expands its presence in peptide-based APIs

New organisational structure consolidates virus filtration, testing services, and CDMO operations to enhance service delivery for…

US pharma manufacturing sees investment surge amid tariff shifts, while BRICS nations push regulatory reforms to expand biosimilar…

As the sector adapts to technological advancements, regulatory requirements, and increasing competition, several leadership role…

Tarunesh Madan highlights the evolving leadership landscape in Indian pharma, exploring emerging roles, global expansion…

Acquisition strengthens Granules’ entry into the peptide-based therapeutics market and enhances CDMO capabilities through Senn’s…

Acquisition strengthens capabilities in biologics, ADCs, and integrated drug discovery